Jeffreybr schreef:
Trouwens.. uitslag van de EPAR zal begin November pas komen:
The product, approved by the European Medicines Agency in June, requires a final formal ratification from the European Commission, which is expected by the start of November. Under the brand name Rhucin, it will be submitted for US regulatory approval by the end of this year.